Daniel Torres

The Attractiveness of Investing In FG Nexus Inc (FGNX) is Growing

Daniel Torres

FG Nexus Inc’s recently made public that its Director Mitchell Michael C acquired Company’s shares for reported $0.16 million on ...

Checking in on Coupang Inc (CPNG) after recent insiders movement

Daniel Torres

Coupang Inc’s recent filing unveils that its Officer GAURAV ANAND acquired Company’s shares for reported $2.18 million on Nov 10 ...

Analysts review Healthpeak Properties Inc’s rating

Daniel Torres

In a filing, Healthpeak Properties Inc revealed its Director Thomas John T acquired Company’s shares for reported $24730.0 on Aug ...

Monness Crespi & Hardt upgrades Strategy Inc (MSTR) stock to a Neutral

Daniel Torres

Strategy Inc’s filing revealed that its Officer Shao Wei-Ming acquired Company’s shares for reported $1.33 million on Nov 10 ’25. ...

JP Morgan Downgrades OneMain Holdings Inc (OMF) to a Neutral from an Overweight

Daniel Torres

OneMain Holdings Inc’s recently made public that its Officer Conrad Micah R. acquired Company’s shares for reported $0.3 million on ...

Understanding the Risks of Investing in BlackRock TCP Capital Corp (TCPC)

Daniel Torres

BlackRock TCP Capital Corp’s recent filing unveils that its Director Leets Karen L acquired Company’s shares for reported $24915.0 on ...

Cytek BioSciences Inc [CTKB] Investment Appeal on the Rise

Daniel Torres

In a filing, Cytek BioSciences Inc revealed its Chief Financial Officer McCombe William D. acquired Company’s shares for reported $97300.0 ...

Analyzing Solventum Corp (SOLV) After Recent Trading Activity

Daniel Torres

Solventum Corp’s filing revealed that its 10% Owner 3M CO unloaded Company’s shares for reported $646.36 million on Aug 15 ...

Hain Celestial Group Inc [HAIN] Investment Guide: What You Need to Know

Daniel Torres

Hain Celestial Group Inc’s recently made public that its Director Campbell Neil acquired Company’s shares for reported $95307.0 on Sep ...

The Attractiveness of Investing In Keros Therapeutics Inc (KROS) is Growing

Daniel Torres

Keros Therapeutics Inc’s recent filing unveils that its 10% Owner Pontifax Management 4 G.P. (20 unloaded Company’s shares for reported ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.